Ormetoprim; Sulfadimethoxine

99 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

910.0%

Death Rate

Active Ingredients

Ormetoprim; Sulfadimethoxine

Administration Routes

OralUnknown

Species Affected

Dog 92

Unknown 4

Cat 3

Most Affected Breeds

Retriever - Labrador 21

Terrier - Yorkshire 6

Dog (unknown) 5

Retriever - Golden 5

Boxer (German Boxer) 4

Unknown 4

Shepherd Dog - German 3

Collie (unspecified) 2

Terrier (unspecified) 2

Terrier - Rat 2

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 25

Other abnormal test result NOS 16

Behavioural disorder NOS 16

Anorexia 13

Fever 13

Lack of efficacy (bacteria) - NOS 11

Thrombocytopenia 11

Elevated serum alkaline phosphatase (SAP) 11

Elevated alanine aminotransferase (ALT) 10

Leucocytosis NOS 9

Ataxia 9

Anaemia NOS 8

Outcome Breakdown

Ongoing

53 (55.2%)

Recovered/Normal

19 (19.8%)

Outcome Unknown

15 (15.6%)

Euthanized

6 (6.3%)

Died

3 (3.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.